Literature DB >> 18490020

Osteoprotegerin released from the vascular wall by heparin mainly derives from vascular smooth muscle cells.

Mads Nybo, Lars Melholt Rasmussen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490020     DOI: 10.1016/j.atherosclerosis.2008.03.026

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  6 in total

1.  Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome.

Authors:  D Glintborg; A P Hermann; L M Rasmussen; M Andersen
Journal:  J Endocrinol Invest       Date:  2012-11-26       Impact factor: 4.256

2.  Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants.

Authors:  Lena Tschiderer; Johann Willeit; Georg Schett; Stefan Kiechl; Peter Willeit
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

3.  Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function.

Authors:  Christian Shetelig; Shanmuganathan Limalanathan; Jan Eritsland; Pavel Hoffmann; Ingebjørg Seljeflot; Jon Michael Gran; Pål Aukrust; Thor Ueland; Geir Øystein Andersen
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

4.  Omega 3 fatty acids effect on the vascular calcification biomarkers fetuin A and osteoprotegerin in hemodialysis patients.

Authors:  Rehab H Werida; Sohaila Abou-Madawy; Mohamed Abdelsalam; Maged W Helmy
Journal:  Clin Exp Med       Date:  2021-07-20       Impact factor: 3.984

Review 5.  Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications.

Authors:  Mette Bjerre
Journal:  Springerplus       Date:  2013-12-06

Review 6.  Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease.

Authors:  Stella Bernardi; Fleur Bossi; Barbara Toffoli; Bruno Fabris
Journal:  Biomed Res Int       Date:  2016-04-21       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.